Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors
This is the largest study describing real-world patterns of GLP1 receptor agonists in breast cancer survivors. Clinical trials should evaluate these agents for weight management as an adjunct to lifestyle interventions and the potential role in cancer control in breast cancer survivors.
Authors
- Akshara Singareeka Raghavendra (ORCID: https://orcid.org/0000-0002-6425-4400)
- Roland L. Bassett (ORCID: https://orcid.org/0000-0002-4534-2042)
- Carlos H. Bárcenas (ORCID: https://orcid.org/0000-0001-5377-9167)
- Jasmine Sukumar (ORCID: https://orcid.org/0000-0001-6994-8527)
- H. Colleen Silva (ORCID: https://orcid.org/0000-0002-7077-5675)
- Sarah Pasyar
- Debu Tripathy
- Banu Arun
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Cancer Research Communications
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1158/2767-9764.crc-25-0554
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases